SEC Comment Letter for Idaho Copper Corp (COPR) (CIK 0001263364) (COPR) — Jun 1, 2011
Idaho Copper Corp (COPR) (CIK 0001263364)
Date: June 1, 2011 · CIK: 0001263364 · Accession: 0000000000-11-033823
AI Filing Summary & Sentiment
File numbers found in text: 333-108715
Letter
June 1, 2011 Via Fax and Mail Jinghe Zhang, Chief Executive Officer Joway Health Industries Group In c. (f/k/a G2 Ventures, Inc.) 16th Floor, Tianjin Global Zh iye Square, 309 Nanjing Road, Nankai District, Tianjin, PRC
Re: G2 Ventures, Inc. Form 8-K Filed October 7, 2010 File No. 333-108715
Dear Mr. Zhang: We issued a comment letter to you on th e above captioned filing on April 13, 2011 in connection with our review of your periodic reports. As of th e date of this letter, these comments remain outstanding and unresolved. We expect you to contact us by June 15, 2011 to provide a substantive response to the comments or to advise us why you are unable to respond and when you will be able to do so. If you do not respond to the outstanding comm ents or contact us by June 15, 2011, we will, consistent with our obligati ons under the federal securities laws, decide how we will seek to resolve material outstanding comments and co mplete our review of your filings and your disclosure. Among other things, we may decide to release publicly, through the agency’s EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff’s decision to releas e publicly comment letters and response letters relating to disclosure filings it has reviewed. You can find more information about the staff’s decision to release filing correspondence at http://www.sec.gov/news/press/2004-89.htm and http://www.sec.gov/news/press/2005-72.htm .
Jinghe Zhang Joway Health Industries Group In c. (f/k/a G2 Ventures, Inc.) June 1, 2011 Page 2
You may contact Ethan Horow itz at (202) 551-3311 or Ange la Halac at (202) 551-3398 if you have questions regarding comments on the financial statements and related matters. Please contact Edwin Kim at (202) 551-3297 or Pamela Howell, Special Counsel, at (202) 551- 3357 with any other questions.
Sincerely,
/s/ Pamela Howell for
John Reynolds Assistant Director
Show Raw Text
June 1, 2011 Via Fax and Mail Jinghe Zhang, Chief Executive Officer Joway Health Industries Group In c. (f/k/a G2 Ventures, Inc.) 16th Floor, Tianjin Global Zh iye Square, 309 Nanjing Road, Nankai District, Tianjin, PRC Re: G2 Ventures, Inc. Form 8-K Filed October 7, 2010 File No. 333-108715 Dear Mr. Zhang: We issued a comment letter to you on th e above captioned filing on April 13, 2011 in connection with our review of your periodic reports. As of th e date of this letter, these comments remain outstanding and unresolved. We expect you to contact us by June 15, 2011 to provide a substantive response to the comments or to advise us why you are unable to respond and when you will be able to do so. If you do not respond to the outstanding comm ents or contact us by June 15, 2011, we will, consistent with our obligati ons under the federal securities laws, decide how we will seek to resolve material outstanding comments and co mplete our review of your filings and your disclosure. Among other things, we may decide to release publicly, through the agency’s EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff’s decision to releas e publicly comment letters and response letters relating to disclosure filings it has reviewed. You can find more information about the staff’s decision to release filing correspondence at http://www.sec.gov/news/press/2004-89.htm and http://www.sec.gov/news/press/2005-72.htm . Jinghe Zhang Joway Health Industries Group In c. (f/k/a G2 Ventures, Inc.) June 1, 2011 Page 2 You may contact Ethan Horow itz at (202) 551-3311 or Ange la Halac at (202) 551-3398 if you have questions regarding comments on the financial statements and related matters. Please contact Edwin Kim at (202) 551-3297 or Pamela Howell, Special Counsel, at (202) 551- 3357 with any other questions. Sincerely, /s/ Pamela Howell for John Reynolds Assistant Director